1. Home
  2. NOTV vs MYO Comparison

NOTV vs MYO Comparison

Compare NOTV & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inotiv Inc.

NOTV

Inotiv Inc.

HOLD

Current Price

$0.70

Market Cap

29.9M

Sector

Health Care

ML Signal

HOLD

Logo Myomo Inc.

MYO

Myomo Inc.

HOLD

Current Price

$1.01

Market Cap

33.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NOTV
MYO
Founded
1974
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Specialties
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.9M
33.2M
IPO Year
1997
2017

Fundamental Metrics

Financial Performance
Metric
NOTV
MYO
Price
$0.70
$1.01
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$3.00
$7.67
AVG Volume (30 Days)
1.6M
830.5K
Earning Date
02-04-2026
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$513,024,000.00
$41,643,203.00
Revenue This Year
$6.26
$24.07
Revenue Next Year
$45.49
$17.48
P/E Ratio
N/A
N/A
Revenue Growth
4.54
65.00
52 Week Low
$0.66
$0.71
52 Week High
$6.48
$7.17

Technical Indicators

Market Signals
Indicator
NOTV
MYO
Relative Strength Index (RSI) 31.90 55.62
Support Level $0.79 $1.02
Resistance Level $0.86 $1.13
Average True Range (ATR) 0.07 0.07
MACD 0.00 0.02
Stochastic Oscillator 7.66 59.77

Price Performance

Historical Comparison
NOTV
MYO

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.

About MYO Myomo Inc.

Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).

Share on Social Networks: